GeneralBullishBlockonomi · 5h ago6/10
📰
Nuvalent (NUVL) Stock Soars 39% as GSK Announces $10.6B Acquisition
GlaxoSmithKline announced a $10.6 billion acquisition of Nuvalent at $124 per share, causing the biotech company's stock to surge 39%. This represents GSK's largest acquisition in over a decade and signals significant strategic investment in oncology therapeutics.